Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yin-Yin Qin"'
Autor:
Xiao-Hong Xie, Pan-Xiao Shen, Jian-Hui Wu, Gui-Huan Qiu, Xin-Qing Lin, Zhan-Hong Xie, Yin-Yin Qin, Bin Zheng, Ming Liu, Cheng-Zhi Zhou
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Immune-related adverse events (irAEs) pose a significant challenge for the widespread adoption of immuno-oncology therapies, but their symptoms can vary widely. In particular, the relationship between irAEs and pleural effusion (PE) in patients with
Externí odkaz:
https://doaj.org/article/099d2f6aa9a4458a8a2f7504b8225d26
Autor:
Yuan-yuan Zhou, Bo-kai Zhang, Tian-fei Ran, Song Ke, Tian-ying Ma, Yin-yin Qin, Yuan Zhang, Yuan Xu, Min Wang
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Objective This study aimed to observe the relationship between education level and outcomes after total knee arthroplasty (TKA). Methods One thousand two hundred sixty four patients after TKA in our hospital from April 2016 to April 2020 wer
Externí odkaz:
https://doaj.org/article/bb3846bfa0d642869e072ba95e7704ab
Autor:
Xiao-Hong Xie, Li-Qiang Wang, Yin-Yin Qin, Xin-Qing Lin, Zhan-Hong Xie, Ming Liu, Jie-Xia Zhang, Ming Ouyang, Jun Liu, Ying-Ying Gu, Shi-Yue Li, Cheng-Zhi Zhou
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Objective NUT midline carcinoma (NMC), a rare type of squamous cell carcinoma, is genetically characterised by NUT midline carcinoma family member 1 (NUTM1) gene rearrangement. NMC can arise from the lungs; however, there is no standard for
Externí odkaz:
https://doaj.org/article/3ebf4a94265a492c81c4488f8f3ff2a6
Autor:
Xiao-Hong Xie, Hai-Yi Deng, Xin-Qing Lin, Jian-Hui Wu, Ming Liu, Zhan-Hong Xie, Yin-Yin Qin, Cheng-Zhi Zhou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Pembrolizumab, an immune checkpoint inhibitor (ICI) approved for advanced non-small cell lung cancer (NSCLC) treatment, has shown superior survival benefits. However, pembrolizumab may lead to severe immune-related adverse events (irAEs), such as che
Externí odkaz:
https://doaj.org/article/589143784ecd43f3afe4d26961ba2405
Autor:
Xiao-Hong Xie, Ze-Jiang Zhan, Yin-Yin Qin, Ju-Hong Jiang, Wei-Qiang Yin, Rong-Hui Zheng, Shi-Yue Li, Cheng-Zhi Zhou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The treatment of anaplastic lymphoma kinase (ALK)-positive locally advanced non-small-cell lung cancer (NSCLC) is challenging because there is no randomized controlled trial has been reported. The value of neoadjuvant and adjuvant targeted therapy re
Externí odkaz:
https://doaj.org/article/ce4a235ef7d04f10b2512075f2b4cd23
Publikováno v:
Zhongguo gu shang = China journal of orthopaedics and traumatology. 34(5)
To explore clinical effect of locking plate external fixation combined with membrane induction technology in treating open and comminuted tibial fractures with bone defects.Totally 92 patients of open and comminuted tibial fractures with bone defects
Autor:
Tao Zhang, Wei-Sen Huang, Weijie Guan, Ziying Hong, Jiabo Gao, Guoying Gao, Guofeng Wu, Yin-Yin Qin
Publikováno v:
J Thorac Dis
Since December 2019, the pneumonia cases infected with 2019 novel coronavirus have appeared, posing a critical threat to global health. In this study, we performed a meta-analysis to discover the different clinical characteristics between severe and
Autor:
Cheng-Zhi, Zhou, Yin-Yin, Qin, Zhan-Hong, Xie, Jie-Xia, Zhang, Ming, Ou-Yang, Shi-Yue, Li, Rong-Chang, Chen
Publikováno v:
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. 26(6)
The purposes of this study were to observe the effects of different treatment strategies, including third-line pemetrexed alone versus its combination with bevacizumab, in patients with advanced epidermal growth factor receptor (EGFR) mutation-positi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
CHEST; Dec2010, Vol. 138 Issue 6, p1309-1315, 7p, 1 Diagram, 2 Charts, 2 Graphs